Clinical Trial Update: Doravirine, Rifapentine and Isoniazid Interaction [Phase 1]

View source ↗

Summary

Phase 1 trial update examining interactions between doravirine, rifapentine, and isoniazid in latent tuberculosis and HIV, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Latent Tuberculosis

Drugs mentioned

• Doravirine (doravirine)
• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: Walter K. Kraft | Conditions: Latent Tuberculosis, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED | Results posted: 2020-03-03